Drugs and the FDA: Safety, Efficacy, and the Public's Trust

Main
Drugs and the FDA: Safety, Efficacy,...

Drugs and the FDA: Safety, Efficacy, and the Public's Trust

Mikkael A. Sekeres

5.0 / 5.0

你有多喜歡這本書？

文件的質量如何？

下載本書進行質量評估

下載文件的質量如何？

年:

2022

出版商:

MIT Press

語言:

english

ISBN 10:

0262371316

ISBN 13:

9780262371315

ISBN:

2021051380

文件:

EPUB, 8.57 MB

IPFS:

,

english, 2022

下載 (epub, 8.57 MB)

轉換進行中

轉換為失敗

你可能感興趣

Mikkael A. Sekeres — Drugs and the FDA: Safety, Efficacy, and the Public's Trust

Nathan Vardi — For Blood and Money : : Billionaires, Biotech, and the Quest for a Blockbuster Drug

DAVID CAVAIIA — OFF-IABEI PRESCRIBING-JUSTIFYING UNAPPROVED MEDICINE

Stephen Johnston, Charles Swanton — Handbook of Metastatic Breast Cancer

— AACR Cancer Progress Report 2014

— The Cancer Market Outlook to

Darcy Olsen — The Right to Try

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Bernice Z. Schacter — The New Medicines: How Drugs are Created, Approved, Marketed, and Sold

Leslie A. Pray, Sally Robinson — Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation)

Institute of Medicine — Assessing and Improving Value in Cancer Care: Workshop Summary

Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs — Ethical and scientific issues in studying the safety of approved drugs

Pickert, Kate — Radical: the science, culture, and history of breast cancer in America

Fran Hawthorne — Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat

Carpenter, Daniel P — Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA: Organizational Image and Pharmaceutical Regulation at the FDA

John Somberg — Cardiovascular Drug Development: Protocol Design and Methodology (Fundamental and Clinical Cardiology , Vol 35)

John L. Lamattina(auth.) — Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?

Abutalib, Syed A.;Markman, Maurie — Cancer consult: expert clinical perspective

Cavalla, David — Off-label prescribing : justifying unapproved medicine

Jeffrey S. Barrett — Fundamentals of Drug Development

Syed A. Abutalib, Maurie Markman, James O. Armitage, Kenneth C. Anderson, Hope S. Rugo, Al B. Benson, III — Cancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors & Supportive Care, 2nd Edition

Friedhoff, Lawrence Tim — New drugs: an insider's guide to the FDA's new drug approval process, for scientists, investors, and patients

Vinayak K. Prasad — Malignant: How Bad Policy and Bad Evidence Harm People with Cancer

Vinayak K. Prasad, MD, MPH — Malignant: How Bad Policy and Bad Evidence Harm People with Cancer

Goldberg, Paul;Brawley, Otis Webb — How we do harm: a doctor breaks ranks about being sick in America

J. Rick Turner (auth.) — Key Statistical Concepts in Clinical Trials for Pharma

Michel Pagé PhD (auth.), Beverly A. Teicher PhD, Paul A. Andrews PhD (eds.) — Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval

Williams Ph.D, Ben A — Surviving ''Terminal'' Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About

Margaret Eaton — Ethics and the Business of Bioscience

Beverly Teicher, Paul Andrews — Anticancer Drug Development Guide (Cancer Drug Discovery and Development)

Robert F. Todd III et al. — Tumor Board Review: Guideline and Case Reviews in Oncology

Ralph W. Moss — Cancer, Incorporated

Haidong Dong, Svetomir N. Markovic — The Basics of Cancer Immunotherapy

M. Kaufmann (editor); I. C. Henderson (editor); E. Enghofer (editor) — Therapeutic Management of Metastatic Breast Cancer

最常見的術語